R M Milteer1, S Sarpong, U Poydras. Show Affiliations » 1. Department of Pediatrics, Howard University College of Medicine, District of Columbia General Hospital, Washington, DC 20003.
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, OralCefotaxime/therapeutic useDelayed-Action PreparationsFemaleFerrous Compounds/administration & dosageFerrous Compounds/metabolismFerrous Compounds/poisoningHumansInfantMaleSepsis/drug therapySepsis/etiologyYersinia Infections/drug therapyYersinia Infections/etiologyYersinia enterocolitica/growth & developmentYersinia enterocolitica/isolation & purification
Substances： See more » Delayed-Action PreparationsFerrous Compoundsferrous sulfateCefotaxime
Year: 1989 PMID： 2771534 DOI： 10.1097/00006454-198908000-00016
Source DB: PubMed Journal: Pediatr Infect Dis J ISSN： 0891-3668 Impact factor: 2.129